INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with […]

Oxygen is vital for life, and clinicians can provide supplemental oxygen to patients through face masks and nasal tubes, but there are no methods available for delivering oxygen directly into cells.

Sebia, a global specialty diagnostic company providing solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, an in vitro diagnostic (IVD) company based in New Jersey, U.S., specialized in autoimmune and infectious diseases techno- logies. Financial terms of the agreement are undisclosed.

Kupando, a Berlin-based biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases, has closed its Series A funding round which raised €13 million.

Tokyo-based Showa Denko Materials and Kidswell Bio Corporation, also based in Tokyo have entered into an agreement to enable process development as well as clinical manufacturing of cell therapy products utilizing the advantage of SHED (Stem cells from Human Exfoliated Deciduous teeth) which is under development by Kidswell Bio. Under the terms of agreement, Minaris […]